Marshall Wace’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.99M | Buy |
2,894,072
+1,639,376
| +131% | +$3.39M | 0.01% | 968 |
|
|
2025
Q1 | $2.76M | Buy |
1,254,696
+237,157
| +23% | +$522K | ﹤0.01% | 1242 |
|
|
2024
Q4 | $1.56M | Sell |
1,017,539
-698,006
| -41% | -$1.07M | ﹤0.01% | 1435 |
|
|
2024
Q3 | $3.41M | Sell |
1,715,545
-45,506
| -3% | -$90.6K | ﹤0.01% | 1061 |
|
|
2024
Q2 | $6.16M | Buy |
1,761,051
+1,266,697
| +256% | +$4.43M | 0.01% | 839 |
|
|
2024
Q1 | $1.37M | Buy |
+494,354
| New | +$1.37M | ﹤0.01% | 1327 |
|
|
2019
Q3 | – | Sell |
-68,904
| Closed | -$1.28M | – | 1734 |
|
|
2019
Q2 | $1.28M | Buy |
68,904
+68,701
| +33,843% | +$1.28M | 0.01% | 849 |
|
|
2019
Q1 | $5K | Sell |
203
-20,843
| -99% | -$513K | ﹤0.01% | 1636 |
|
|
2018
Q4 | $546K | Sell |
21,046
-8,864
| -30% | -$230K | 0.01% | 1064 |
|
|
2018
Q3 | $947K | Buy |
+29,910
| New | +$947K | 0.01% | 821 |
|
|
2018
Q2 | – | Sell |
-12,100
| Closed | -$334K | – | 753 |
|
|
2018
Q1 | $334K | Buy |
+12,100
| New | +$334K | 0.01% | 452 |
|